Biohaven says public offering of common shares priced at $51.75/shr

Biohaven announces pricing of $250 million public offering of common shares.biohaven pharmaceutical holding - pricing of underwritten public offering of 4.8 million of common shares at price to public of $51.75 per share.

BHVN Ratings Summary

BHVN Quant Ranking